Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026)
Impact Biomedical's Cash & Equivalents was $21,000 in Q3 2026, up 75.0% from $12,000 a year earlier and up 110.0% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Impact Biomedical came in at $3,000, down 99.8% from FY2024.
- Cash & Equivalents shows a three-year compound annual growth rate of 14.5% (FY2022 to FY2025).
- In earlier years, Cash & Equivalents was $2 million in FY2024, $1,000 in FY2023 (-50.0%) and $2,000 in FY2022.
- The Q3 2026 figure marks the highest quarterly Cash & Equivalents since Q2 2025.
- Compared with a year earlier, Cash & Equivalents was higher in 1 of the last five quarters, with an average decline of 64.3%.
- Per Business Quant data, IBO's Cash & Equivalents in the three quarters before Q3 2026 was $10,000 (Q2 2026), $20,000 (Q1 2026) and $3,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | 21,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21,000.00 |
| Jun 30, 2026 | 10,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 624,000.00 |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Dec 31, 2022 | 2,000.00 |
API Access
Impact Biomedical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();